A detailed history of Pathstone Holdings, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Pathstone Holdings, LLC holds 17,741 shares of RDY stock, worth $1.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,741
Previous 17,001 4.35%
Holding current value
$1.32 Million
Previous $1.25 Million 8.34%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$68.26 - $76.19 $50,512 - $56,380
740 Added 4.35%
17,741 $1.35 Million
Q1 2024

May 13, 2024

SELL
$67.36 - $77.59 $82,920 - $95,513
-1,231 Reduced 6.75%
17,001 $1.25 Million
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $1.17 Million - $1.27 Million
18,232 New
18,232 $1.27 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $12.3B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.